Xenetic Biosciences annual capital expenditures (capex)
2012
2013
2013
2014
2015
2016
2017
2018
2022
Xenetic Biosciences Capital Expenditures (CapEx) Growth & History (XBIO)
Xenetic Biosciences's capital expenditures (capex) was $500,000 for fiscal 2022.
View full Xenetic Biosciences company overviewXenetic Biosciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $500,000 | — | — |
| 2018 | 2018-12-31 | $0 | −$9,264 | — |
| 2017 | 2017-12-31 | $9,264 | −$7,529 | −44.83% |
| 2016 | 2016-12-31 | $16,793 | $15,130 | +909.80% |
| 2015 | 2015-12-31 | $1,663 | −$56,006 | −97.12% |
| 2014 | 2014-12-31 | $57,669 | −$20,965 | −26.66% |
| 2013 · Dec 31 | 2013-12-31 | $78,634 | −$51,450 | −39.55% |
| 2013 · Aug 31 | 2013-08-31 | $212,500 | — | — |
| 2012 · Dec 31 | 2012-12-31 | $130,084 | — | — |
Xenetic Biosciences quarterly capital expenditures (capex)
Q3.12
Q1.13
Q1.13
Q1.13
Q2.13
Q2.13
Q3.13
Q1.14
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | −$3,835 | — |
| Q1 2018 | 2018-03-31 | $0 | −$5,429 | — |
| Q4 2017 | 2017-12-31 | $0 | −$2,180 | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $3,835 | $3,835 | — |
| Q1 2017 | 2017-03-31 | $5,429 | −$9,184 | −62.85% |
| Q4 2016 | 2016-12-31 | $2,180 | $2,180 | — |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | −$1,663 | — |
| Q1 2016 | 2016-03-31 | $14,613 | $14,613 | — |
| Q4 2015 | 2015-12-31 | $0 | −$11,660 | — |
| Q3 2015 | 2015-09-30 | $0 | −$6,425 | — |
| Q2 2015 | 2015-06-30 | $1,663 | −$20,929 | −92.64% |
| Q1 2015 | 2015-03-31 | $0 | −$16,992 | — |
| Q4 2014 | 2014-12-31 | $11,660 | — | — |
| Q3 2014 | 2014-09-30 | $6,425 | $1,450 | +29.15% |
| Q2 2014 | 2014-06-30 | $22,592 | $16,853 | +293.66% |
| Q1 2014 · Mar 31 | 2014-03-31 | $16,992 | $12,902 | +315.45% |
| Q1 2014 · Nov 30 | 2013-11-30 | $212,500 | $0 | 0.00% |
| Q3 2013 | 2013-09-30 | $4,975 | — | — |
| Q2 2013 · Jun 30 | 2013-06-30 | $5,739 | — | — |
| Q2 2013 · May 31 | 2013-05-31 | $0 | $0 | — |
| Q1 2013 · Mar 31 | 2013-03-31 | $4,090 | — | — |
| Q1 2013 · Feb 28 | 2013-02-28 | $0 | — | — |
| Q1 2013 · Nov 30 | 2012-11-30 | $212,500 | — | — |
| Q3 2012 | 2012-05-31 | $0 | — | — |
Xenetic Biosciences capital expenditures (capex) trends
Over the last five fiscal years, Xenetic Biosciences's capital expenditures (capex) increased from $9,264 to $500,000, a change of $490,736. The latest reported quarter, Q4 2018, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xenetic Biosciences source filings ↗